PurAmino, a complete portfolio with the toddler amino acid formula that has DHA

  • PurAmino: A 100% amino acid-based formula that helps eliminate dietary allergens while having DHA for infants and toddlers


    PurAmino: A 100% amino acid-based formula that helps eliminate dietary allergens while having DHA for infants and toddlers


    Formulated with 33% MCT oil* to help facilitate fat absorption

    • 100% of infants fed PurAmino had no allergic reactions or adverse events1ɫ‡
    • Results were reported in infants and children with documented CMA1
    • ≈80% of infants and children also had multiple food allergies1

    Proven to support normal growth1,*


    Similar weight gain to infants fed Nutramigen® over 4 months’ time.1,*

    Proven to support normal growth - boys

    Proven to support normal growth - girls

    • Weight gain from day 14 to days 30, 60, 90 and 120 was similar in both groups1
    • Study included healthy, full-term infants1

    PurAmino Infant


    Proven hypoallergenic

    • Helps eliminates cow’s milk protein allergens from the diet

    Additional formulation benefits

    • Low osmolality: 350 mOsm/kg H2O
    • Fatty acid profile: 47% of calories from fat
    • 42% of Calories from carbohydrates; suitable for someone with lactose intolerance
    • Kosher and halal

    PurAmino Toddler offers all of the same great nutrients as PurAmino Infant


    PurAmino Infant has DHA as recommended by experts§

    PurAmino Infant—has DHA to help support mental, visual, and immune system development.2-7

    PurAmino Toddler has calcium and protein for growing toddlers

    PurAmino Infant and Toddler: also suitable for gut impairment conditions that require an elemental diet


    • Multiple food protein intolerance
    • Short bowel syndrome
    • Protein maldigestion
    • Eosinophilic esophagitis
    • Malabsorption

    *of the fat blend ɫ Studied before the reformulation ‡ Study did not include PurAmino Toddler. Studied before the reformulation. § PurAmino has not been shown superior to Neocate or EleCare in supporting infant development and health

    References: 1. Burks W et al. J Pediatr. 2008;153:266-271. 2. Birch EE, Hoffman DR, Castañeda YS, et al. A randomized controlled trial of long–chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr. 2002;75:570–580. 3. Hoffman DR, Birch EE, Castañeda YS, et al. Maturation of visual and mental function in 18–month old infants receiving dietary long–chain polyunsaturated fatty acids [abstract]. FASEB J. 2003;17:A727–A728. Abstract 445.1. 4.Hoffman DR, Birch EE, Castañeda YS, et al. Visual function in breast–fed term infants weaned to formula with or without long–chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr. 2003;142:669–677. 5. Hoffman DR, Birch EE, Birch DG, et al. Impact of early dietary intake and blood lipid composition of long–chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540–553. 6. Birch EE, Castañeda YS, Wheaton DH, et al. Visual maturation of term infants fed long–chain polyunsaturated fatty acid–supplemented or control formula for 12 mo. Am J Clin Nutr. 2005;81:871–879. 7. Morale SE, Hoffman DR, Castañeda YS, et al. Duration of long–chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev. 2005;81:197–203.